0000899243-21-042078.txt : 20211029
0000899243-21-042078.hdr.sgml : 20211029
20211029192301
ACCESSION NUMBER: 0000899243-21-042078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211028
FILED AS OF DATE: 20211029
DATE AS OF CHANGE: 20211029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Primiano Christopher Brett
CENTRAL INDEX KEY: 0001603510
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40971
FILM NUMBER: 211364817
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 85 WELLS AVENUE, SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aura Biosciences, Inc.
CENTRAL INDEX KEY: 0001501796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 320271970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 BOLTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617)500-8864
MAIL ADDRESS:
STREET 1: 85 BOLTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-28
0
0001501796
Aura Biosciences, Inc.
AURA
0001603510
Primiano Christopher Brett
C/O AURA BIOSCIENCES, INC.
85 BOLTON STREET
CAMBRIDGE
MA
02140
0
1
0
0
Chief Business Officer
Common Stock
2021-10-28
4
A
0
8750
0.00
A
8750
D
Stock Option (Right to Buy)
14.00
2021-10-28
4
A
0
37500
A
2031-10-27
Common Stock
37500
37500
D
These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.
The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2022 with the remainder vesting thereafter in annual installments.
/s/ Julie Feder
2021-10-29